Compare Novo Nordisk A/S (NVO) vs Sea Limited (SE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novo Nordisk A/S vs Sea Limited — how do they compare? Novo Nordisk A/S trades at $45.8 (market cap $207.85B), while Sea Limited trades at $129.95 (market cap $80.55B). The key difference: Novo Nordisk A/S is far larger — about 2.6× Sea Limited's market cap, and Novo Nordisk A/S pays a 3.81% dividend while Sea Limited pays none. Which is the better fit depends on your goals.
| NVO | SE | |
|---|---|---|
Market Cap | $207.85B | $80.55B |
Sector | Health | Media |
52-Week High | $63.98 | $196.50 |
52-Week Low | $35.29 | $78.16 |
Enterprise Value | $222.55B | $75.58B |
Dividend Yield | 3.81% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →About Sea Limited
Sea Limited offers information technology services. The Company provides online personal computer and mobile digital content, e-commerce, and payment platforms. Sea serves customers worldwide.
Read more on SE →
